A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...

Fusobacterium nucleatum, a bacterium linked to colorectal cancer, possesses a specific gene called fadA that serves as an early diagnostic biomarker. The CRISPR/Cas12a system has demonstrated marked ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of animal husbandry. Traditional nucleic acid detection methods such as PCR ...

During her postdoctoral fellowship at Harvard’s Wyss Institute, Professor Nicole Weckman (ISTEP, ChemE) developed a new technique to rapidly detect antimicrobial resistant genes in a pathogenic fungus ...

The Myhrvold lab develops CRISPR-based technologies for studying RNA. Our primary interest is RNAs involved in host-pathogen interactions. We use a variety of RNA viruses and other pathogens as model ...

Twisted graphene precisely aligned with gold nanodisks and coupled with CRISPR achieves attomolar detection of cancer biomarkers, revealing a new path for low light molecular diagnostics. (Nanowerk ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based ...

Oceanic ecosystems are increasingly threatened by global warming, which causes coral bleaching, species migration and, ...